摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]oct-1-en-7-yn-2-yl] trifluoromethanesulfonate | 191849-74-8

中文名称
——
中文别名
——
英文名称
[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]oct-1-en-7-yn-2-yl] trifluoromethanesulfonate
英文别名
——
[(3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]oct-1-en-7-yn-2-yl] trifluoromethanesulfonate化学式
CAS
191849-74-8
化学式
C21H39F3O5SSi2
mdl
——
分子量
516.77
InChiKey
FMNFAWSSJQNYSD-MSOLQXFVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    498.9±45.0 °C(Predicted)
  • 密度:
    1.070±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.56
  • 重原子数:
    32
  • 可旋转键数:
    12
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    70.2
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of Side-Chain Locked Analogs of 1α,25-Dihydroxyvitamin D<sub>3</sub> Bearing a C17 Methyl Group
    作者:Rita Sigüeiro、Miguel A. Maestro、Antonio Mouriño
    DOI:10.1021/acs.orglett.8b00849
    日期:2018.5.4
    A convergent synthesis of side-chain locked vitamin D analogs 3 and 4, which bind strongly in silico to the vitamin D receptor (VDR), is described. The synthetic approach features an SN2′-syn displacement of carbamates by cuprates to set the challenging quaternary stereogenic center at C17 and a Pd-catalyzed construction of the triene system in the presence of a diyne moiety.
    描述了侧链锁定的维生素D类似物3和4的会聚合成,其在计算机上与维生素D受体(VDR)牢固地结合。合成方法的特征是通过酸盐将氨基甲酸酯进行SN2'-syn置换,以在C17处设置具有挑战性的四级立体异构中心,并在二炔部分存在的情况下,催化三烯系统的构建。
  • Carborane-based design of a potent vitamin D receptor agonist
    作者:Rocio Otero、Samuel Seoane、Rita Sigüeiro、Anna Y. Belorusova、Miguel A. Maestro、Roman Pérez-Fernández、Natacha Rochel、Antonio Mouriño
    DOI:10.1039/c5sc03084f
    日期:——

    The development of a promising clinical antitumor vitamin D analog possessing a side-chain o-carborane cluster that efficiently binds to VDR by unconventional dihydrogen bonding (BH⋯HN) is described.

    描述了一种具有侧链o-碳硼烷簇的有前景的临床抗肿瘤维生素D类似物的发展,该类似物通过非传统的双氢键(BH⋯HN)有效结合到维生素D受体(VDR)。
  • An Expeditious Route to 1α,25-Dihydroxyvitamin D<sub>3</sub>and Its Analogues by an Aqueous Tandem Palladium-Catalyzed A-Ring Closure and Suzuki Coupling to the C/D Unit
    作者:Pranjal Gogoi、Rita Sigüeiro、Silvina Eduardo、Antonio Mouriño
    DOI:10.1002/chem.200902972
    日期:2010.2.1
    mild, general, and highly stereoselective Pd0catalyzed cascade to the triene system of the hormone 1α,25‐dihydroxyvitamin D3 and six representative analogues is reported. The intramolecular cyclization of an enol–triflate (lower fragment) followed in situ by Suzuki–Miyaura coupling with an alkenyl boronic ester (upper fragment, also efficiently prepared by Pd0catalyzed coupling) in equimolar amounts
    每日维生素:有轻度,一般和高度立体选择性的Pd 0催化与1α,25-二羟基维生素D 3和6种代表性类似物的三烯系统级联。在质子化条件下等摩尔量的烯醇-三氟甲磺酸分子的分子内环化(下片段),然后是铃木-宫浦(Suzuki-Miyaura)与烯基硼酸酯(上片段,也可通过Pd 0催化偶联有效制备)原位合成用于生物测试的少量新维生素D类似物(请参阅计划)。
  • Synthesis of (1<i>α</i>)-1,25-Dihydroxyvitamin D<sub>3</sub>with a<i>β</i>-Positioned Seven-Carbon Side Chain at C(12)
    作者:Diego M. Carballa、Antonio Rumbo、Mercedes Torneiro、Miguel Maestro、Antonio Mouriño
    DOI:10.1002/hlca.201200427
    日期:2012.10
    A convergent synthesis of an analogue of (1α)‐1,25‐dihydroxyvitamin D3 (1b) with a C7 side chain at C(12), i.e., of 5 (Fig.), is described. A key step of the synthesis is the assembly of the triene system by a PdII‐catalyzed ring closure of an enol triflate (‘bottom’ fragment) followed by coupling of the resulting PdII intermediate with an alkenylboronate (‘upper’ fragment) (Scheme 2). The synthetic
    (1个的类似物的汇集合成α)-1,25二羟基维生素d 3(图1b)与C 7侧链C(12),即,的5(图),进行说明。合成的关键步骤是通过Pd II催化的烯丙基三氟甲磺酸酯(“底部”片段)的闭环来组装三烯系统,然后将所得的Pd II中间体与烯基硼酸酯(“上部”片段)偶联(方案2)。合成策略允许在合成结束时进行同位素标记。
  • Design, Synthesis, Evaluation and Structure of Allenic 1α,25‐Dihydroxyvitamin D <sub>3</sub> Analogs with Locked Mobility at C‐17
    作者:Ramón Fraga、Kateryna Len、Regis Lutzing、Gilles Laverny、Julian Loureiro、Miguel A. Maestro、Natacha Rochel、Enrique Rodriguez‐Borges、Antonio Mouriño
    DOI:10.1002/chem.202101578
    日期:2021.9.20
    disorders related to the immune system. However, hypercalcemic effects limit their therapeutical uses and call for the development of tissue-selective new analogs. We have designed and synthesized the first examples of 1α,25-dihydroxyvitamin D3 analogs bearing an allenic unit attached to the D ring to restrict the side-chain conformational mobility. The triene system was constructed by a Pd0-mediated
    维生素 D 受体配体具有治疗过度增殖性疾病和与免疫系统相关的疾病的潜力。然而,高血症作用限制了它们的治疗用途,并需要开发组织选择性的新类似物。我们设计并合成了第一个 1α,25-二羟基维生素 D 3类似物的例子,其带有连接到 D 环的联烯单元,以限制侧链构象移动性。三烯系统是在丙二烯侧链存在下通过Pd 0介导的环化/Suzuki-Miyaura交叉偶联过程构建的。丙二烯部分是通过炔丙醇的原酸酯-克莱森重排构建的。(22 S )-1α,25-二羟基-17,20-dien-24-homo-21-nor-vitamin D 3与维生素 D 受体结合域结合的生物活性和结构,提供有关侧链的信息生物活性的构象要求。
查看更多